Hence then, the article about innovent presents updated data from innovative anti cldn18 2 adc ibi343 phase 1 study in patients with advanced pancreatic cancer at the esmo asia congress 2024 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Innovent Presents Updated Data From Innovative Anti-CLDN18.2 ADC (IBI343) Phase 1 Study in Patients with Advanced Pancreatic Cancer at the ESMO Asia Congress 2024 )
Last updated :
Also on site :
- The devil wears Old Navy? Inside Hollywood’s favorite movie marketing blitz
- India in talks with US and Iran on key port – Foreign Ministry
- How a Spanish startup pivoted to video AI and built a $230 million ARR business with no VC funding